Scott D. Bringans

6 Verdun Street
Perth, WA 6009, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 30 publications

Prognostic value of a plasma protein-based biomarker test for chronic kidney disease complicating diabetes in Aboriginal Australians.

Prognostic value of a plasma protein-based biomarker test for chronic kidney disease complicating diabetes in Aboriginal Australians.

Journal: Internal medicine journal

Published: August 04, 2025

A Clinical Validation of a Diagnostic Test for Esophageal Adenocarcinoma Based on a Novel Serum Glycoprotein Biomarker Panel: PromarkerEso.

A Clinical Validation of a Diagnostic Test for Esophageal Adenocarcinoma Based on a Novel Serum Glycoprotein Biomarker Panel: PromarkerEso.

Journal: Proteomes

Published: April 03, 2025

Analytical and Clinical Performance of a Novel Immunoassay-Based Test System to Predict Diabetic Kidney Disease.

Analytical and Clinical Performance of a Novel Immunoassay-Based Test System to Predict Diabetic Kidney Disease.

Journal: The journal of applied laboratory medicine

Published: February 24, 2025

PromarkerD Versus Standard of Care Biochemical Measures for Assessing Future Renal Function Decline in Type 2 Diabetes.

PromarkerD Versus Standard of Care Biochemical Measures for Assessing Future Renal Function Decline in Type 2 Diabetes.

Journal: Diagnostics (Basel, Switzerland)

Published: February 06, 2025

Application of Proteomic Methods in Oomycete Biology.

Application of Proteomic Methods in Oomycete Biology.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: December 27, 2024

Identification of plasma protein biomarkers for endometriosis and the development of statistical models for disease diagnosis.

Identification of plasma protein biomarkers for endometriosis and the development of statistical models for disease diagnosis.

Journal: Human reproduction (Oxford, England)

Published: June 18, 2024

Application of a validated prognostic plasma protein biomarker test for renal decline in type 2 diabetes to type 1 diabetes: the Fremantle Diabetes Study Phase II.

Application of a validated prognostic plasma protein biomarker test for renal decline in type 2 diabetes to type 1 diabetes: the Fremantle Diabetes Study Phase II.

Journal: Clinical diabetes and endocrinology

Published: May 08, 2024

Canagliflozin Attenuates PromarkerD Diabetic Kidney Disease Risk Prediction Scores.

Canagliflozin Attenuates PromarkerD Diabetic Kidney Disease Risk Prediction Scores.

Journal: Journal of clinical medicine

Published: February 28, 2023

Semi-Automated Lectin Magnetic Bead Array (LeMBA) for Translational Serum Glycoprotein Biomarker Discovery and Validation.

Semi-Automated Lectin Magnetic Bead Array (LeMBA) for Translational Serum Glycoprotein Biomarker Discovery and Validation.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: February 13, 2023

Immunoaffinity Mass Spectrometry Diagnostic Tests for Multi-Biomarker Assays.

Immunoaffinity Mass Spectrometry Diagnostic Tests for Multi-Biomarker Assays.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: February 13, 2023

Pyroxasulfone-Resistant Annual Ryegrass (Lolium rigidum) Has Enhanced Capacity for Glutathione Transferase-Mediated Pyroxasulfone Conjugation.

Pyroxasulfone-Resistant Annual Ryegrass (Lolium rigidum) Has Enhanced Capacity for Glutathione Transferase-Mediated Pyroxasulfone Conjugation.

Journal: Journal of agricultural and food chemistry

Published: June 03, 2021

Gene Validation and Remodelling Using Proteogenomics of Phytophthora cinnamomi, the Causal Agent of Dieback.

Gene Validation and Remodelling Using Proteogenomics of Phytophthora cinnamomi, the Causal Agent of Dieback.

Journal: Frontiers in microbiology

Published: February 08, 2021

Showing 1-12 of 30

Last Updated: 09/26/2026